Zymeworks
Utility Patents

Last updated:

List of all Zymeworks patents 24 in total

Status Patent
Grant
Utility: Bispecific antigen-binding constructs targeting Her2 External link
Filling date: 26 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Modified antigen binding polypeptide constructs and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 19 Apr 2022
Grant
Utility: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Multivalent heteromultimer scaffold design and constructs External link
Filling date: 26 Sep 2025 Issue date: 15 Feb 2022
Grant
Utility: Antibodies comprising C-terminal light chain polypeptide extensions and conjugates and methods of use thereof External link
Filling date: 26 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 2 Nov 2021
Grant
Utility: Methods for determining correlated residues in a protein or other biopolymer using molecular dynamics External link
Filling date: 26 Sep 2025 Issue date: 19 Oct 2021
Grant
Utility: Drug-conjugated bi-specific antigen-binding constructs External link
Filling date: 26 Sep 2025 Issue date: 19 Oct 2021
Grant
Utility: Heteromultimers with reduced or silenced effector function External link
Filling date: 26 Sep 2025 Issue date: 24 Aug 2021
Grant
Utility: Engineered immunoglobulin heavy chain-light chain pairs and uses thereof External link
Filling date: 26 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Anti-PD-1/LAG3 bispecific antibodies External link
Filling date: 26 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Antigen-binding constructs targeting HER2 External link
Filling date: 26 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Systems and methods for identifying thermodynamically relevant polymer conformations External link
Filling date: 26 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Anti-HER2 biparatopic antibody-drug conjugates and methods of use External link
Filling date: 26 Sep 2025 Issue date: 11 May 2021
Grant
Utility: Bispecific antigen-binding constructs targeting HER2 External link
Filling date: 26 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Stable heterodimeric antibody design with mutations in the Fc domain External link
Filling date: 26 Sep 2025 Issue date: 29 Dec 2020
Grant
Utility: Multivalent heteromultimer scaffold design and constructs External link
Filling date: 26 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: VAR2CSA-drug conjugates External link
Filling date: 26 Sep 2025 Issue date: 9 Jun 2020
Grant
Utility: Compositions and methods for the treatment of platinum-drug resistant cancer External link
Filling date: 26 Sep 2025 Issue date: 31 Dec 2019
Grant
Utility: Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells External link
Filling date: 26 Sep 2025 Issue date: 17 Dec 2019
Grant
Utility: Systems and methods for sampling and analysis of polymer conformational dynamics External link
Filling date: 26 Sep 2025 Issue date: 19 Nov 2019
Grant
Utility: Stable heterodimeric antibody design with mutations in the Fc domain External link
Filling date: 26 Sep 2025 Issue date: 29 Oct 2019
Grant
Utility: Cytotoxic and anti-mitotic compounds, and methods of using the same External link
Filling date: 26 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Cytotoxic and anti-mitotic compounds, and methods of using the same External link
Filling date: 26 Sep 2025 Issue date: 17 Sep 2019

Showing 1 to 24 of 24 patents.